Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Davis

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses|May 31, 2002
The nursing shortage: whose problem is it anyway?Susan H Davis
Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses|March 19, 2003
Glossary of legal termsSusan H Davis
Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses|June 14, 2003
No profession is without risk: what one state is doing ... KentuckySusan H Davis
Mbio|January 25, 2023
Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosisFrancesca G Tomasi, Jessica T P Schweber, Satoshi Kimura, et al.
Journal of Medicinal Chemistry|March 18, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal TrypanosomiasisAlasdair Smith, Richard J Wall, Stephen Patterson, et al.
Journal of Medicinal Chemistry|August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of TuberculosisSusan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
ACS Omega|February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> GrowthPeter C Ray, Margaret Huggett, Penelope A Turner, et al.
Nature Communications|October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugsSimon R Green, Susan H Davis, Sebastian Damerow, et al.
ACS Infectious Diseases|October 6, 2016
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosisYumi Park, Angela Pacitto, Tracy Bayliss, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses|May 31, 2002
The nursing shortage: whose problem is it anyway?Susan H Davis
Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses|March 19, 2003
Glossary of legal termsSusan H Davis
Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses|June 14, 2003
No profession is without risk: what one state is doing ... KentuckySusan H Davis
Mbio|January 25, 2023
Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosisFrancesca G Tomasi, Jessica T P Schweber, Satoshi Kimura, et al.
Journal of Medicinal Chemistry|March 18, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal TrypanosomiasisAlasdair Smith, Richard J Wall, Stephen Patterson, et al.
Journal of Medicinal Chemistry|August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of TuberculosisSusan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
ACS Omega|February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> GrowthPeter C Ray, Margaret Huggett, Penelope A Turner, et al.
Nature Communications|October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugsSimon R Green, Susan H Davis, Sebastian Damerow, et al.
ACS Infectious Diseases|October 6, 2016
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosisYumi Park, Angela Pacitto, Tracy Bayliss, et al.
Pageof 1